[go: up one dir, main page]

SE457055B - Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser - Google Patents

Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Info

Publication number
SE457055B
SE457055B SE8603481A SE8603481A SE457055B SE 457055 B SE457055 B SE 457055B SE 8603481 A SE8603481 A SE 8603481A SE 8603481 A SE8603481 A SE 8603481A SE 457055 B SE457055 B SE 457055B
Authority
SE
Sweden
Prior art keywords
vasopressin
mucosa
tglvp
radiation protection
gel
Prior art date
Application number
SE8603481A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603481L (sv
SE8603481D0 (sv
Inventor
K F Aronsen
G Nylander
S Borgstroem
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8603481A priority Critical patent/SE457055B/sv
Publication of SE8603481D0 publication Critical patent/SE8603481D0/xx
Priority to FI890715A priority patent/FI890715A7/fi
Priority to EP87850244A priority patent/EP0265400B1/fr
Priority to JP62504940A priority patent/JPH02500668A/ja
Priority to PCT/SE1987/000359 priority patent/WO1988001163A1/fr
Priority to AT87850244T priority patent/ATE64308T1/de
Priority to DE8787850244T priority patent/DE3770753D1/de
Priority to AU78528/87A priority patent/AU609417B2/en
Priority to IL83566A priority patent/IL83566A/xx
Publication of SE8603481L publication Critical patent/SE8603481L/
Priority to NO881580A priority patent/NO881580L/no
Priority to DK206688A priority patent/DK206688A/da
Publication of SE457055B publication Critical patent/SE457055B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Details Of Aerials (AREA)
  • Support Of Aerials (AREA)
  • Colloid Chemistry (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Cosmetics (AREA)
SE8603481A 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser SE457055B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
AU78528/87A AU609417B2 (en) 1986-08-18 1987-08-14 Topical radioprotective gel for mucosa
PCT/SE1987/000359 WO1988001163A1 (fr) 1986-08-18 1987-08-14 Gel radioprotecteur topique pour les muqueuses
EP87850244A EP0265400B1 (fr) 1986-08-18 1987-08-14 Gel topique radio protectif pour muqueuses
JP62504940A JPH02500668A (ja) 1986-08-18 1987-08-14 粘膜用局部的放射線防護ゲル
FI890715A FI890715A7 (fi) 1986-08-18 1987-08-14 Paikallinen, säteilyltä suojaava geeli limakalvoja varten
AT87850244T ATE64308T1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
DE8787850244T DE3770753D1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
IL83566A IL83566A (en) 1986-08-18 1987-08-17 Radioprotective gel containing vasoconstrictors for topical application on mucosa
NO881580A NO881580L (no) 1986-08-18 1988-04-12 Lokal straalingsbeskyttende gel for slimhinne.
DK206688A DK206688A (da) 1986-08-18 1988-04-15 Topisk straalebeskyttende gel for mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Publications (3)

Publication Number Publication Date
SE8603481D0 SE8603481D0 (sv) 1986-08-18
SE8603481L SE8603481L (sv) 1988-02-19
SE457055B true SE457055B (sv) 1988-11-28

Family

ID=20365336

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Country Status (11)

Country Link
EP (1) EP0265400B1 (fr)
JP (1) JPH02500668A (fr)
AT (1) ATE64308T1 (fr)
AU (1) AU609417B2 (fr)
DE (1) DE3770753D1 (fr)
DK (1) DK206688A (fr)
FI (1) FI890715A7 (fr)
IL (1) IL83566A (fr)
NO (1) NO881580L (fr)
SE (1) SE457055B (fr)
WO (1) WO1988001163A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005661A1 (fr) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Compositions pharmaceutiques a base de vasopressine
EP0496433B1 (fr) * 1987-10-22 1999-03-24 The Procter & Gamble Company Compositions photoprotectrices contenant des agents chélatants
CA2323237C (fr) * 1998-03-10 2009-05-19 University Of Southern California Methodes ameliorees de radiotherapie
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
PT1331927E (pt) * 2000-10-27 2008-01-30 Leo Pharma As Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide
CA2501981A1 (fr) 2002-10-01 2004-04-15 Mitos Pharmaceuticals, Inc. Preparations de radioprotection a l'oxyde d'azote et leurs methodes d'utilisation
US7183255B2 (en) * 2003-02-26 2007-02-27 Intradialytic Pharmaceuticals Method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
DK1890732T3 (en) 2005-06-17 2018-07-02 Wisconsin Alumni Res Found TOPICAL VASO CONSTRUCTOR PREPARATIONS AND METHODS FOR PROTECTING CELLS UNDER CANCER THERAPY AND RADIATION THERAPY
AU2007215406B2 (en) 2006-02-10 2011-12-08 Ferring B.V Novel compounds
EP2175874A2 (fr) 2007-08-14 2010-04-21 Ferring B.V. Utilisation d'agonistes peptidiques du récepteur de la vasopressine
WO2014062380A2 (fr) * 2012-10-16 2014-04-24 Rohm And Haas Company Gels aqueux contenant un émollient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785103A (en) * 1953-12-31 1957-03-12 Abbott Lab L-desoxyephedrine inhalant preparation
CH455823A (de) * 1964-08-01 1968-05-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von Peptiden
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
DE3106619A1 (de) * 1981-02-23 1982-09-09 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitung in form eines mikroklysmas

Also Published As

Publication number Publication date
SE8603481L (sv) 1988-02-19
ATE64308T1 (de) 1991-06-15
WO1988001163A1 (fr) 1988-02-25
AU609417B2 (en) 1991-05-02
IL83566A (en) 1991-06-10
IL83566A0 (en) 1988-01-31
FI890715L (fi) 1989-02-15
EP0265400B1 (fr) 1991-06-12
JPH02500668A (ja) 1990-03-08
EP0265400A2 (fr) 1988-04-27
NO881580D0 (no) 1988-04-12
DK206688D0 (da) 1988-04-15
DK206688A (da) 1988-06-13
SE8603481D0 (sv) 1986-08-18
DE3770753D1 (de) 1991-07-18
NO881580L (no) 1988-05-30
AU7852887A (en) 1988-03-08
FI890715A0 (fi) 1989-02-15
EP0265400A3 (en) 1988-11-09
FI890715A7 (fi) 1989-02-15

Similar Documents

Publication Publication Date Title
SE457055B (sv) Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
Fassoulaki et al. Intransal adminstration of nitroglycerine attenuates the pressor responsive to laryngoscopy and intubation of the trachea
Stoney et al. The incidence of venous thrombosis following long-term transvenous pacing
Grondin et al. Influence of a critical coronary artery stenosis on myocardial protection through cold potassium cardioplegia
Zalewski et al. Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with intermittent occlusion.
UA77640C2 (uk) Водна фармацевтична композиція для нанесення на слизову оболонку носа
Hilton et al. Perfusion of the isolated adrenals in situ
DE69102704T2 (de) Orales, melatonin enthaltendes arzneimittel.
Altura Evidence that endogenous vasopressin plays a protective role in circulatory shock. Role for reticuloendothelial system using Brattleboro rats
Fagbemi et al. Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia
GB2194147A (en) Topical preparations containing nicotinamides
GB2203044A (en) Nasal compositions
Huang et al. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs
Fawaz Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation
Aggarwal et al. Phrenic nerve palsy: a rare complication of indwelling subclavian vein catheter
Lu et al. Antiarrhythmic effects of nebivolol in experimental models in vivo
Curtis et al. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats
Nahor et al. Effect of celiac blockade and dibenzyline on traumatic shock following release of occluded superior mesenteric artery
Hatori et al. Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion
WILSON et al. In extremis use of a Foley catheter in a cardiac stab wound
Chinushi et al. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.
EP3946379A1 (fr) Agents polymères pour réanimation cardiopulmonaire
RU2371183C2 (ru) Трансдермальные стероидные композиции
Sheehan et al. The effects of nitroglycerin-methoxamine combination on infarct size in conscious dogs
Miller et al. Contribution of systemic venous hypertension to the development of pulmonary edema in dogs.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8603481-6

Effective date: 19920306

Format of ref document f/p: F